GPR160 is a potential biomarker associated with prostate cancer.

MLA

Guo, Wanjing, et al. “GPR160 Is a Potential Biomarker Associated with Prostate Cancer.” Signal Transduction & Targeted Therapy, vol. 6, no. 1, June 2021, pp. 1–3. EBSCOhost, https://doi.org/10.1038/s41392-021-00583-7.

APA

Guo, W., Zhang, J., Zhou, Y., Zhou, C., Yang, Y., Cong, Z., Dong, J., Yang, D., Dai, B., & Wang, M.-W. (2021). GPR160 is a potential biomarker associated with prostate cancer. Signal Transduction & Targeted Therapy, 6(1), 1–3. https://doi.org/10.1038/s41392-021-00583-7

Chicago

Guo, Wanjing, Junyu Zhang, Yan Zhou, Caihong Zhou, Yunjie Yang, Zhaotong Cong, Jibin Dong, Dehua Yang, Bo Dai, and Ming-Wei Wang. 2021. “GPR160 Is a Potential Biomarker Associated with Prostate Cancer.” Signal Transduction & Targeted Therapy 6 (1): 1–3. doi:10.1038/s41392-021-00583-7.